Results 141 to 150 of about 69,966 (266)
Zhongshan Daxue xuebao. Yixue kexue ban, 1984 乙型肝炎病毒（HBV）是属于嗜肝DNA病毒（Hepadna）的一种,完整病毒颗粒（Dane颗粒）的核心部分,含有双股环状脱氧核糖核酸（DNA）,近年来对HBV DNA的研究取得迅速发展,HBV DNA克隆成功,而且可以用切口翻译方法把32P标记上克隆的HBV DNA,把它作为探针与血清中提取的DNA杂交,检测血清标本中是否存在HBV DNA,提供一种极为灵敏的检测血清中HBV的方法,我们开展了这个检测项目,应用斑点杂交试验直接检查血清标本的HBV DNA。
郑锡澄
doaj
Transfusion, EarlyView.Abstract Background In 2022, Canadian Blood Services implemented a gender‐neutral sexual behavior‐based screening (SBBS) approach to donor deferral, replacing time‐based criteria targeting gay, bisexual and other men who have sex with men (gbMSM) and female partners of gbMSM. We assessed the impact of this policy change on human immunodeficiency virus (
Chinchin Wang +3 more
wiley +1 more source
Relation of Hbv-DNA levels between serum alanin aminotransferases and serologıc markers of HBV
, 2006 Amaç: Serum HBV-DNA miktarları ile yaş, cinsiyet, serum alanin aminotransferaz (ALT) düzeyleri arasındaki ilişki varlığını incelemek. Gereç ve Yöntem: Bu çalışmada serum HBV-DNA miktarları bilinen 90 hastanın yaş, cinsiyet, serum alanin aminotransferaz ...
Zeynep Sümer +3 more
core
Liver International, Volume 46, Issue 8, August 2026.ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu +11 more
wiley +1 more source
Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line.
, 1985 Using molecular hybridization we studied the presence and state of HBV DNA in sperm samples obtained from 17 patients with HBV infection (eight HBsAg chronic carrier, nine acute hepatitis B).
Degos F +6 more
core
Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma
Liver International, Volume 46, Issue 8, August 2026.ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah +2 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 7, July 2026.ABSTRACT Weil's disease should be considered even in non‐endemic regions when compatible clinical findings are accompanied by relevant exposure history. This case is epidemiologically notable as the first documented report from South Khorasan Province, highlighting the diagnostic challenges of leptospirosis in non‐endemic settings and the potential ...
Zohreh Azarkar +3 more
wiley +1 more source
Detection of HBV DNA in the Sera of HBV Carriers by Spot Hybridization Test
Journal of the Japanese Association for Infectious Diseases, 1986 I, Tamura +4 more
openaire +3 more sources
Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
MedComm, Volume 7, Issue 7, July 2026.Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen +6 more
wiley +1 more source